News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
832,362 Results
Type
Article (79007)
Company Profile (803)
Press Release (752519)
Multimedia
Podcasts (211)
Webinars (33)
Section
Business (223144)
Career Advice (3115)
Deals (38084)
Drug Delivery (169)
Drug Development (88875)
Employer Resources (178)
FDA (17893)
Job Trends (16906)
News (379336)
Policy (36895)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3038)
Academic (2)
Accelerated approval (47)
Adcomms (38)
Allergies (184)
Alliances (55420)
ALS (221)
Alzheimer's disease (1922)
Antibody-drug conjugate (ADC) (491)
Approvals (18190)
Artificial intelligence (765)
Autoimmune disease (304)
Automation (57)
Bankruptcy (365)
Best Places to Work (12614)
BIOSECURE Act (22)
Biosimilars (235)
Biotechnology (479)
Bladder cancer (194)
Brain cancer (79)
Breast cancer (785)
Cancer (6098)
Cardiovascular disease (522)
Career advice (2645)
Career pathing (48)
CAR-T (356)
CDC (71)
Celiac Disease (3)
Cell therapy (980)
Cervical cancer (48)
Clinical research (76090)
Collaboration (2241)
Company closure (8)
Compensation (1420)
Complete response letters (98)
COVID-19 (2999)
CRISPR (118)
C-suite (1187)
Cystic fibrosis (162)
Data (7948)
Decentralized trials (3)
Denatured (74)
Depression (184)
Dermatology (86)
Diabetes (618)
Diagnostics (7462)
Digital health (61)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (366)
Drug pricing (241)
Drug shortages (39)
Duchenne muscular dystrophy (299)
Earnings (96018)
Editorial (76)
Employer branding (22)
Employer resources (159)
Events (133676)
Executive appointments (1158)
FDA (21735)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1830)
Gene editing (257)
Generative AI (76)
Gene therapy (800)
GLP-1 (1226)
Government (5355)
Grass and pollen (8)
Guidances (413)
Healthcare (21005)
HIV (87)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (338)
Immuno-oncology (102)
Indications (189)
Infectious disease (3366)
Inflammatory bowel disease (239)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (297)
Interviews (564)
IPO (17605)
IRA (61)
Job creations (4670)
Job search strategy (2207)
JPM (73)
Kidney cancer (21)
Labor market (96)
Layoffs (655)
Leadership (47)
Legal (8971)
Liver cancer (107)
Longevity (34)
Lung cancer (797)
Lymphoma (436)
Machine learning (62)
Management (61)
Manufacturing (1113)
MASH (202)
Medical device (15096)
Medtech (15216)
Mergers & acquisitions (21764)
Metabolic disorders (1652)
mRNA (242)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (462)
Neuropsychiatric disorders (123)
Neuroscience (3552)
Neurotech (1)
NextGen: Class of 2026 (7607)
Non-profit (5120)
Now hiring (76)
Obesity (802)
Opinion (362)
Ovarian cancer (227)
Pain (272)
Pancreatic cancer (309)
Parkinson's disease (384)
Partnered (38)
Patents (621)
Patient recruitment (695)
Peanut (67)
People (65682)
Pharmaceutical (137)
Pharmacy benefit managers (36)
Phase 1 (23598)
Phase 2 (33143)
Phase 3 (24942)
Pipeline (8623)
Policy (374)
Postmarket research (3275)
Preclinical (10628)
Press Release (72)
Prostate cancer (308)
Psychedelics (68)
Radiopharmaceuticals (350)
Rare diseases (1180)
Real estate (7149)
Recruiting (76)
Regulatory (28309)
Reports (51)
Research institute (2751)
Resumes & cover letters (475)
Rett syndrome (37)
RNA editing (25)
RSV (97)
Schizophrenia (191)
Series A (313)
Series B (224)
Service/supplier (29)
Sickle cell disease (120)
Special edition (31)
Spinal muscular atrophy (186)
Sponsored (54)
Startups (4151)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (134)
Vaccines (1236)
Venture capital (121)
Weight loss (549)
Women's health (129)
Worklife (23)
Date
Today (148)
Last 7 days (966)
Last 30 days (3458)
Last 365 days (32640)
2026 (12605)
2025 (32578)
2024 (37825)
2023 (42483)
2022 (53866)
2021 (58631)
2020 (57537)
2019 (51177)
2018 (38908)
2017 (36047)
2016 (36484)
2015 (42689)
2014 (37184)
2013 (34396)
2012 (34877)
2011 (34906)
2010 (34258)
Location
Africa (1129)
Alabama (100)
Alaska (7)
Arizona (355)
Arkansas (16)
Asia (49598)
Australia (8701)
California (13629)
Canada (3816)
China (1427)
Colorado (588)
Connecticut (604)
Delaware (417)
Europe (113677)
Florida (2021)
Georgia (445)
Hawaii (4)
Idaho (66)
Illinois (1151)
India (95)
Indiana (635)
Iowa (24)
Japan (547)
Kansas (140)
Kentucky (56)
Louisiana (46)
Maine (88)
Maryland (1670)
Massachusetts (9951)
Michigan (399)
Minnesota (758)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (147)
New Hampshire (92)
New Jersey (3639)
New Mexico (34)
New York (3574)
North Carolina (1845)
North Dakota (11)
Northern California (6734)
Ohio (421)
Oklahoma (26)
Oregon (55)
Pennsylvania (2708)
Puerto Rico (30)
Rhode Island (53)
South America (1465)
South Carolina (87)
South Dakota (2)
Southern California (5341)
Tennessee (216)
Texas (2204)
United States (48793)
Utah (409)
Vermont (1)
Virginia (351)
Washington D.C. (87)
Washington State (1127)
West Virginia (4)
Wisconsin (152)
Wyoming (2)
832,362 Results for "purdue pharma l p research and development new jersey".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial
April 8, 2026
·
6 min read
Press Releases
START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey
Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets
April 30, 2026
·
1 min read
Press Releases
START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey
April 30, 2026
·
4 min read
Press Releases
Entos Pharmaceuticals and the L-CMD Research Foundation Collaborate to Develop Curative Therapy for LMNA-Related Congenital Muscular Dystrophy
April 21, 2026
·
3 min read
Job Trends
9 Companies Hiring in New Jersey
Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.
December 11, 2025
·
1 min read
·
Chantal Dresner
Press Releases
Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program
February 24, 2026
·
6 min read
Sponsored by Sino Biological
Advances in RSV Vaccine Research and Development
Epidemiology, Next-Generation Vaccine Platforms, and the Critical Role of Prefusion F Antigens in RSV Research
May 11, 2026
·
7 min read
Press Releases
Ardena Opens New Bioanalytical Laboratory in Somerset, New Jersey
April 15, 2026
·
2 min read
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Press Releases
GenScript Leaders Named Entrepreneur Of The Year® 2026 New Jersey Finalists
April 23, 2026
·
2 min read
1 of 83,237
Next
